Clinical trial
Pharmacologic Modulation of Hippocampal Activity in Psychosis
NCT04277936 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacologic Modulation of Hippocampal Activity in Psychosis
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 11, 2020
- Completion date
- August 31, 2020
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia; psychosis